By harnessing the power of nanoparticles, nanomachines, and other cutting-edge nano-scale technologies, we will develop a new generation of bioenhancers that can precisely target, monitor, and manipulate the body’s cellular and molecular processes. These bioenhancers will not only enhance the efficacy of therapeutic interventions but also proactively maintain and rejuvenate the body’s systems, ushering in a new era of personalized, preventive, and restorative healthcare.
From the nano-scale repair of damaged tissues to the targeted delivery of tailored treatments, these bioenhancers will revolutionize the management of diseases, from cancer and neurodegenerative disorders to metabolic conditions and age-related decline. By seamlessly integrating with the body’s natural mechanisms, these nano-bioenhancers will empower individuals to take control of their health, unlock their physical and cognitive potential, and enjoy longer, healthier, and more fulfilling lives.
Bioenhancz Vs Nanoencapsulation
Targeted Delivery & Specificity
Improved Biocompatibility & Safety
Multifunctional Design
Multimodal Functionality
SynergisticEffects
Controlled Release &Pharmacokinetics
Key Features of BioenhanczTM
“BioenhanczTM is the nanoengineered natural that unlocks the full potential of therapeutic bioactives by dramatically boosting their bioavailability through a multifaceted arsenal of permeability enhancement, efflux pump inhibition, metabolic enzyme modulation, and solubility optimization – transforming even the most challenging drugs/bioactives into powerful, well-absorbed treatment, without compromising safety and stability
Patent & Awards
U.S. Provisional Patent Application No.: 63/517,659
Entitled: QUERCETIN COCRYSTALS AS A BIOENHANCER OF DRUGS AND NUTRIENTS, PROCESS OF ITS PREPARATION
Filing Date: 04-Aug-2023
Platinum medal
PRIX EIFFEL 2022
Applicable Industries
Medical & Pharma
(e.g. Reduced Toxicity Tylenol Drug)
Nutraceutical
(e.g. Fast-Acting Supplement, Nootropics)
Pet Food & Treat
(e.g. Improved Health & Function Supplement)
Sport Drink & Food
(e.g. Enhanced Performance & Physical Function Drink Supplement)
BioEnhancz™ has been investigated for its potential to reduce the hepatotoxicity of cannabidiol (through the inhibition of elevation of hepatic enzymes) which could be extended to the application of other highly hepatotoxicity of APIs, e.g. Acetaminophen (Tylenol/Paracetamol). BioEnhancz™ affects the inactivation the conversion of acetaminophen to its toxic metabolite, N-acetyl-p-benzoquinoneimine (NAPQI).
This metabolite is primarily formed by the cytochrome P4502E1 (CYP2E1) metabolic pathway when acetaminophen is administered at therapeutic doses or overdose.
The research findings indicating that BioEnhancz™ inhibits cytochrome P4502E1 (CYP2E1) which inhibits the conversion of acetaminophen to NAPQI demonstrating the potential benefits of BioEnhancz™ in reducing hepatotoxicity related APIs.
